St. Mary's Medical Center is a hospital in Huntington, West Virginia, USA. With 393 beds, it is the second largest medical facility in the tri-state region wherein West Virginia, Ohio, and Kentucky meet following King's Daughters Medical Center in Ashland, Kentucky which has 465 beds.

There are 393 beds in St. Mary's Medical Center.

During the past decade, St. Mary's Medical Center conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 35 clinical trials were completed, i.e. on average, 94.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 24 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Mary's Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 30 trials, followed by "National Cancer Institute (NCI)" with 15 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "Boston Scientific Corporation" with 9 trials sponsored and "Abbott Medical Devices" with 9 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mary's Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "Canadian Cancer Trials Group" with 3 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "St. Mary's Medical Center" are "Lung Cancer" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Coronary Artery Disease" (5 trials) and "Heart Failure" (5 trials). Many other conditions were trialed in "St. Mary's Medical Center" in a lesser frequency.

Most popular intervention types in "St. Mary's Medical Center" are "Drug" (58 trials), "Other" (31 trials), "Biological" (21 trials), "Device" (21 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (8 trials), "Paclitaxel" (7 trials), "gemcitabine hydrochloride" (7 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "St. Mary's Medical Center" are 89 trials for "All" genders, 7 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "St. Mary's Medical Center". undefined are not yet recruiting, 5 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 63 completed trials in St. Mary's Medical Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in St. Mary's Medical Center, 2 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".

St. Mary's Medical Center has several departments that took part in Clinical trials: "St. Mary's Regional Cancer Center at St. Mary's Medical Center" - 14 trials